Skip to content
港險通Hong Kong Insurance ConnectAsk a broker

Smart Elite Ultra Critical Illness Insurance Plan | AIA International Limited | Fulfillment ratios

Past fulfillment ratios do not indicate future performance. Non-guaranteed benefits can change. These tables provide general information, without rankings or product recommendations.

Coverage is limited to the verified sources listed below, not every insurer or historical year. Grouped cohorts and policy durations remain as published; missing or N/A values are not zero. Published names and notes may remain in the source language. Unknown publication dates are stated explicitly.

Public JSON and insurer shards

Published observations

Filters load the selected insurer data on demand. Results keep insurer and product alphabetical order; values are never used to sort. Clear fields to include all cohorts.

Published observations
Insurer / publisherProduct seriesCurrencyIssue / effective yearPublished cohort / durationReporting yearComponentPublished valueSource
AIA International LimitedSmart Elite Ultra Critical Illness Insurance PlanAll202420242025Annual dividends100%SourcepData
AIA International LimitedSmart Elite Ultra Critical Illness Insurance PlanAll202320232025Annual dividends100%SourcepData
AIA International LimitedSmart Elite Ultra Critical Illness Insurance PlanAll202220222025Annual dividends100%SourcepData
AIA International LimitedSmart Elite Ultra Critical Illness Insurance PlanAll202120212025Annual dividends122%SourcepData
AIA International LimitedSmart Elite Ultra Critical Illness Insurance PlanAll202020202025Annual dividends96%SourcepData
AIA International LimitedSmart Elite Ultra Critical Illness Insurance PlanAll201920192025Annual dividends74%SourcepData
AIA International LimitedSmart Elite Ultra Critical Illness Insurance PlanAll201820182025Annual dividends75%SourcepData
AIA International LimitedSmart Elite Ultra Critical Illness Insurance PlanAll201720172025Annual dividends75%SourcepData
AIA International LimitedSmart Elite Ultra Critical Illness Insurance PlanAll201620162025Annual dividends76%(6)SourcepData
Published notes and source context

(6)

AIA International LimitedSmart Elite Ultra Critical Illness Insurance PlanAll201520152025Annual dividendsNot yet launchedSourcepData
AIA International LimitedSmart Elite Ultra Critical Illness Insurance PlanAll—Before 20152025Annual dividendsNot yet launchedSourcepData
AIA International LimitedSmart Elite Ultra Critical Illness Insurance PlanAll202420242025Terminal dividendsN.A.(5)SourcepData
Published notes and source context

(5)

AIA International LimitedSmart Elite Ultra Critical Illness Insurance PlanAll202320232025Terminal dividendsN.A.(5)SourcepData
Published notes and source context

(5)

AIA International LimitedSmart Elite Ultra Critical Illness Insurance PlanAll202220222025Terminal dividendsN.A.(5)SourcepData
Published notes and source context

(5)

AIA International LimitedSmart Elite Ultra Critical Illness Insurance PlanAll202120212025Terminal dividendsN.A.(5)SourcepData
Published notes and source context

(5)

AIA International LimitedSmart Elite Ultra Critical Illness Insurance PlanAll202020202025Terminal dividends105%SourcepData
AIA International LimitedSmart Elite Ultra Critical Illness Insurance PlanAll201920192025Terminal dividends105%SourcepData
AIA International LimitedSmart Elite Ultra Critical Illness Insurance PlanAll201820182025Terminal dividends104%SourcepData
AIA International LimitedSmart Elite Ultra Critical Illness Insurance PlanAll201720172025Terminal dividends103%SourcepData
AIA International LimitedSmart Elite Ultra Critical Illness Insurance PlanAll201620162025Terminal dividendsN.A.(5)SourcepData
Published notes and source context

(5)

AIA International LimitedSmart Elite Ultra Critical Illness Insurance PlanAll201520152025Terminal dividendsNot yet launchedSourcepData
AIA International LimitedSmart Elite Ultra Critical Illness Insurance PlanAll—Before 20152025Terminal dividendsNot yet launchedSourcepData

Page 1 / 1 / 22

Source

Source attribution only; copyright remains with each publisher. No open-data licence has been established.